Code No. | BMP052 | Print out |
Anti-SLC6A14 (ATB0+) (Human) pAb | ||
Price | ¥60,000 | |
Size | 50 µL | |
Availability (in Japan) | 10 or more
(In Japan at 17:00, Mar 28, 2024 in JST) |
|
Clonality | Polyclonal | |
Clone | Polyclonal | |
Isotype (Immunized Animal) |
Rabbit Ig (aff.) | |
Applications | WB 1:1,000 FCM 1:1,000 IC 1:1,000 IH 1:5,000 (Heat treatment is necessary for paraffin embedded sections.) |
|
Immunogen (Antigen) |
Human SLC6A14-derived synthetic peptide | |
Reactivity [Gene ID] | Human[11254] |
|
Storage buffer | PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | solute carrier family 6 member 14, BMIQ11 | |
Background | SLC6A14, also known as ATB0+, is a member of the Na+ - and Cl- - dependent neurotransmitter transporter family, and is highly expressed in the lung, fetal lung, trachea, and salivary gland. SLC6A14 transports both neutral and cationic amino acids, and has about 60% amino acid similarity with the glycine transporters GLYT1 and GLYT2. The blockade of ATB0+ in cancer cell lines is associated with cell cycle arrest, indicating the potential of ATB0+ as a drug target in cancer chemotherapy. | |
Related products | PM035 Normal Rabbit IgG |
|
Data | ||
Citations | Western Blotting
|